Free Trial
NYSEMKT:PHGE

BiomX (PHGE) Stock Price, News & Analysis

BiomX logo
$0.48 -0.26 (-35.05%)
Closing price 03:58 PM Eastern
Extended Trading
$0.49 +0.01 (+1.88%)
As of 07:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About BiomX Stock (NYSEMKT:PHGE)

Key Stats

Today's Range
$0.72
$0.78
50-Day Range
$0.48
$0.62
52-Week Range
$0.46
$4.60
Volume
53,300 shs
Average Volume
82,359 shs
Market Capitalization
$12.56 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$21.00
Consensus Rating
Buy

Company Overview

BiomX Inc., a clinical-stage biopharmaceutical company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria associated with chronic disease. It is developing BX211, a phage therapy, which is in phase 2 clinical study for the treatment of diabetic foot osteomyelitis. The company's product pipeline also includes BX004, a phage therapy for cystic fibrosis patients with chronic pulmonary infections caused by Pseudomonas aeruginosa that is in Phase 1b/2a clinical trials. BiomX Inc. was founded in 2015 and is headquartered in Ness Ziona, Israel.

Receive PHGE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BiomX and its competitors with MarketBeat's FREE daily newsletter.

PHGE Stock News Headlines

A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
BiomX announces going concern qualification from independent audit
See More Headlines

PHGE Stock Analysis - Frequently Asked Questions

BiomX's stock was trading at $0.7301 on January 1st, 2025. Since then, PHGE shares have decreased by 34.3% and is now trading at $0.48.
View the best growth stocks for 2025 here
.

BiomX Inc. (NYSEMKT:PHGE) issued its earnings results on Monday, May, 15th. The company reported ($2.00) earnings per share for the quarter, missing the consensus estimate of ($1.80) by $0.20.

BiomX's stock reverse split on Monday, August 26th 2024. The 1-10 reverse split was announced on Thursday, August 15th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Friday, August 23rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

BiomX's top institutional investors include Nantahala Capital Management LLC (9.97%), Alyeska Investment Group L.P. (6.36%), AIGH Capital Management LLC (6.27%) and Allostery Investments LP (3.76%). Insiders that own company stock include Israel Biofund Gp Limi Orbimed, Chidozie Ugwumba and Assaf Oron.
View institutional ownership trends
.

Shares of PHGE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that BiomX investors own include Predictive Oncology (POAI), JPMorgan Chase & Co. (JPM), Abbott Laboratories (ABT), NVIDIA (NVDA), Zomedica (ZOM), Insulet (PODD) and Ford Motor (F).

Company Calendar

Last Earnings
5/15/2023
Today
5/30/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSEMKT
Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSEMKT:PHGE
Fax
N/A
Employees
120
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$21.00
High Stock Price Target
$21.00
Low Stock Price Target
$21.00
Potential Upside/Downside
+4,275.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$28.32 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$0.70 per share
Price / Book
0.69

Miscellaneous

Free Float
44,044,000
Market Cap
$12.56 million
Optionable
Not Optionable
Beta
1.51
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NYSEMKT:PHGE) was last updated on 5/30/2025 by MarketBeat.com Staff
From Our Partners